These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Lip GY; Laroche C; Dan GA; Santini M; Kalarus Z; Rasmussen LH; Ioachim PM; Tica O; Boriani G; Cimaglia P; Diemberger I; Hellum CF; Mortensen B; Maggioni AP Am J Med; 2014 Jun; 127(6):519-29.e1. PubMed ID: 24486284 [TBL] [Abstract][Full Text] [Related]
9. Atrial fibrillation. Lip GY; Tse HF; Lane DA Lancet; 2012 Feb; 379(9816):648-61. PubMed ID: 22166900 [TBL] [Abstract][Full Text] [Related]
10. Is bleeding a necessary evil? The inherent risk of antithrombotic pharmacotherapy used for stroke prevention in atrial fibrillation. Myat A; Ahmad Y; Haldar S; Tantry US; Redwood SR; Gurbel PA; Lip GY Expert Rev Cardiovasc Ther; 2013 Aug; 11(8):1029-49. PubMed ID: 23984927 [TBL] [Abstract][Full Text] [Related]
11. [Anticoagulation in atrial fibrillation. Strategies in special situations]. Volkmann H; Walter M; Walter C; Vetter S Clin Res Cardiol Suppl; 2011 May; 6():58-65. PubMed ID: 22528179 [TBL] [Abstract][Full Text] [Related]
12. Balancing bleeding and thrombotic risk with new oral anticoagulants in patients with atrial fibrillation. Overvad TF; Larsen TB; Albertsen IE; Rasmussen LH; Lip GY Expert Rev Cardiovasc Ther; 2013 Dec; 11(12):1619-29. PubMed ID: 24215192 [TBL] [Abstract][Full Text] [Related]
13. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban. Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583 [TBL] [Abstract][Full Text] [Related]
15. Warfarin in non-valvular atrial fibrillation. Dalby AJ; Wessels P; Opie LH S Afr Med J; 2013 Oct; 103(12):901-4. PubMed ID: 24300625 [TBL] [Abstract][Full Text] [Related]
16. Stroke prevention in atrial fibrillation: an update on current management strategies. Hall T; Stanton T; Wang WY; Ng AC Panminerva Med; 2013 Mar; 55(1):43-58. PubMed ID: 23474663 [TBL] [Abstract][Full Text] [Related]
17. Developing an Atrial Fibrillation Guideline Support Tool (AFGuST) for shared decision making. Eckman MH; Wise RE; Naylor K; Arduser L; Lip GY; Kissela B; Flaherty M; Kleindorfer D; Khan F; Schauer DP; Kues J; Costea A Curr Med Res Opin; 2015 Apr; 31(4):603-14. PubMed ID: 25690491 [TBL] [Abstract][Full Text] [Related]
18. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation. Hylek EM Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532 [No Abstract] [Full Text] [Related]
19. Dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: NICE guidance. Ahmad Y; Lip GY Heart; 2012 Oct; 98(19):1404-6. PubMed ID: 22698856 [No Abstract] [Full Text] [Related]
20. New Oral Anticoagulants: Need and Challenges in a Developing Country. Khan M; Wasay M J Coll Physicians Surg Pak; 2016 Jul; 26(7):551-2. PubMed ID: 27504541 [No Abstract] [Full Text] [Related] [Next] [New Search]